Left Ventricular Geometry and Blood Pressure as Predictors of Adverse Progression of Fabry Cardiomyopathy.

<h4>Background</h4>In spite of several research studies help to describe the heart in Fabry disease (FD), the cardiomyopathy is not entirely understood. In addition, the impact of blood pressure and alterations in geometry have not been systematically evaluated.<h4>Methods</h4&g...

Full description

Bibliographic Details
Main Authors: Johannes Krämer, Bart Bijnens, Stefan Störk, Christian O Ritter, Dan Liu, Georg Ertl, Christoph Wanner, Frank Weidemann
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0140627
_version_ 1818402314400038912
author Johannes Krämer
Bart Bijnens
Stefan Störk
Christian O Ritter
Dan Liu
Georg Ertl
Christoph Wanner
Frank Weidemann
author_facet Johannes Krämer
Bart Bijnens
Stefan Störk
Christian O Ritter
Dan Liu
Georg Ertl
Christoph Wanner
Frank Weidemann
author_sort Johannes Krämer
collection DOAJ
description <h4>Background</h4>In spite of several research studies help to describe the heart in Fabry disease (FD), the cardiomyopathy is not entirely understood. In addition, the impact of blood pressure and alterations in geometry have not been systematically evaluated.<h4>Methods</h4>In 74 FD patients (mean age 36±12 years; 45 females) the extent of myocardial fibrosis and its progression were quantified using cardiac magnetic-resonance-imaging with late enhancement technique (LE). Results were compared to standard echocardiography complemented by 2D-speckle-tracking, 3D-sphericity-index (SI) and standardized blood pressure measurement. At baseline, no patient received enzyme replacement therapy (ERT). After 51±24 months, a follow-up examination was performed.<h4>Results</h4>Systolic blood pressure (SBP) was higher in patients with vs. without LE: 123±17 mmHg vs. 115±13 mmHg; P = 0.04. A positive correlation was found between SI and the amount of LE-positive myocardium (r = 0.51; P<0.001) indicating an association of higher SI in more advanced stages of the cardiomyopathy. SI at baseline was positively associated with the increase of LE-positive myocardium during follow-up. The highest SBP (125±19 mmHg) and also the highest SI (0.32±0.05) was found in the subgroup with a rapidly increasing LE (ie, ≥0.2% per year; n = 16; P = 0.04). Multivariate logistic regression analysis including SI, SBP, EF, left ventricular volumes, wall thickness and NT-proBNP adjusted for age and sex showed SI as the most powerful parameter to detect rapid progression of LE (AUC = 0.785; P<0.05).<h4>Conclusions</h4>LV geometry as assessed by the sphericity index is altered in relation to the stage of the Fabry cardiomyopathy. Although patients with FD are not hypertensive, the SBP has a clear impact on the progression of the cardiomyopathy.
first_indexed 2024-12-14T08:06:24Z
format Article
id doaj.art-c2b1340583c94556ab75829ebf349179
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-14T08:06:24Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-c2b1340583c94556ab75829ebf3491792022-12-21T23:10:11ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011011e014062710.1371/journal.pone.0140627Left Ventricular Geometry and Blood Pressure as Predictors of Adverse Progression of Fabry Cardiomyopathy.Johannes KrämerBart BijnensStefan StörkChristian O RitterDan LiuGeorg ErtlChristoph WannerFrank Weidemann<h4>Background</h4>In spite of several research studies help to describe the heart in Fabry disease (FD), the cardiomyopathy is not entirely understood. In addition, the impact of blood pressure and alterations in geometry have not been systematically evaluated.<h4>Methods</h4>In 74 FD patients (mean age 36±12 years; 45 females) the extent of myocardial fibrosis and its progression were quantified using cardiac magnetic-resonance-imaging with late enhancement technique (LE). Results were compared to standard echocardiography complemented by 2D-speckle-tracking, 3D-sphericity-index (SI) and standardized blood pressure measurement. At baseline, no patient received enzyme replacement therapy (ERT). After 51±24 months, a follow-up examination was performed.<h4>Results</h4>Systolic blood pressure (SBP) was higher in patients with vs. without LE: 123±17 mmHg vs. 115±13 mmHg; P = 0.04. A positive correlation was found between SI and the amount of LE-positive myocardium (r = 0.51; P<0.001) indicating an association of higher SI in more advanced stages of the cardiomyopathy. SI at baseline was positively associated with the increase of LE-positive myocardium during follow-up. The highest SBP (125±19 mmHg) and also the highest SI (0.32±0.05) was found in the subgroup with a rapidly increasing LE (ie, ≥0.2% per year; n = 16; P = 0.04). Multivariate logistic regression analysis including SI, SBP, EF, left ventricular volumes, wall thickness and NT-proBNP adjusted for age and sex showed SI as the most powerful parameter to detect rapid progression of LE (AUC = 0.785; P<0.05).<h4>Conclusions</h4>LV geometry as assessed by the sphericity index is altered in relation to the stage of the Fabry cardiomyopathy. Although patients with FD are not hypertensive, the SBP has a clear impact on the progression of the cardiomyopathy.https://doi.org/10.1371/journal.pone.0140627
spellingShingle Johannes Krämer
Bart Bijnens
Stefan Störk
Christian O Ritter
Dan Liu
Georg Ertl
Christoph Wanner
Frank Weidemann
Left Ventricular Geometry and Blood Pressure as Predictors of Adverse Progression of Fabry Cardiomyopathy.
PLoS ONE
title Left Ventricular Geometry and Blood Pressure as Predictors of Adverse Progression of Fabry Cardiomyopathy.
title_full Left Ventricular Geometry and Blood Pressure as Predictors of Adverse Progression of Fabry Cardiomyopathy.
title_fullStr Left Ventricular Geometry and Blood Pressure as Predictors of Adverse Progression of Fabry Cardiomyopathy.
title_full_unstemmed Left Ventricular Geometry and Blood Pressure as Predictors of Adverse Progression of Fabry Cardiomyopathy.
title_short Left Ventricular Geometry and Blood Pressure as Predictors of Adverse Progression of Fabry Cardiomyopathy.
title_sort left ventricular geometry and blood pressure as predictors of adverse progression of fabry cardiomyopathy
url https://doi.org/10.1371/journal.pone.0140627
work_keys_str_mv AT johanneskramer leftventriculargeometryandbloodpressureaspredictorsofadverseprogressionoffabrycardiomyopathy
AT bartbijnens leftventriculargeometryandbloodpressureaspredictorsofadverseprogressionoffabrycardiomyopathy
AT stefanstork leftventriculargeometryandbloodpressureaspredictorsofadverseprogressionoffabrycardiomyopathy
AT christianoritter leftventriculargeometryandbloodpressureaspredictorsofadverseprogressionoffabrycardiomyopathy
AT danliu leftventriculargeometryandbloodpressureaspredictorsofadverseprogressionoffabrycardiomyopathy
AT georgertl leftventriculargeometryandbloodpressureaspredictorsofadverseprogressionoffabrycardiomyopathy
AT christophwanner leftventriculargeometryandbloodpressureaspredictorsofadverseprogressionoffabrycardiomyopathy
AT frankweidemann leftventriculargeometryandbloodpressureaspredictorsofadverseprogressionoffabrycardiomyopathy